Last reviewed · How we verify

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin

University of British Columbia · FDA-approved active Small molecule

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin is a Fluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran Small molecule drug developed by University of British Columbia. It is currently FDA-approved for Urinary tract infections, Bacterial respiratory infections, Gastrointestinal infections. Also known as: Keflex, Macrobid, co-trimoxazole.

This is a combination of three distinct antibacterial agents that work through different mechanisms to inhibit bacterial growth and kill bacteria.

This is a combination of three distinct antibacterial agents that work through different mechanisms to inhibit bacterial growth and kill bacteria. Used for Urinary tract infections, Bacterial respiratory infections, Gastrointestinal infections.

At a glance

Generic nameciprofloxacin, cotrimoxazole-trimethoprim, macrodantin
Also known asKeflex, Macrobid, co-trimoxazole
SponsorUniversity of British Columbia
Drug classFluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran
TargetBacterial DNA gyrase, topoisomerase IV, dihydrofolate reductase, bacterial DNA
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

Ciprofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication. Cotrimoxazole (sulfamethoxazole-trimethoprim) is a sulfonamide-diaminopyrimidine combination that sequentially blocks bacterial folate synthesis. Nitrofurantoin (macrodantin) generates reactive oxygen species that damage bacterial DNA and proteins. Together, these agents provide broad-spectrum coverage against gram-positive and gram-negative bacteria.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin

What is ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin is a Fluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran drug developed by University of British Columbia, indicated for Urinary tract infections, Bacterial respiratory infections, Gastrointestinal infections.

How does ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin work?

This is a combination of three distinct antibacterial agents that work through different mechanisms to inhibit bacterial growth and kill bacteria.

What is ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin used for?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin is indicated for Urinary tract infections, Bacterial respiratory infections, Gastrointestinal infections, Skin and soft tissue infections.

Who makes ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin is developed and marketed by University of British Columbia (see full University of British Columbia pipeline at /company/university-of-british-columbia).

Is ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin also known as anything else?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin is also known as Keflex, Macrobid, co-trimoxazole.

What drug class is ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin in?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin belongs to the Fluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran class. See all Fluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran drugs at /class/fluoroquinolone-sulfonamide-diaminopyrimidine-combination-nitrofuran.

What development phase is ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin in?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin is FDA-approved (marketed).

What are the side effects of ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin?

Common side effects of ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin include Nausea, Diarrhea, Headache, Photosensitivity (ciprofloxacin), Rash, Peripheral neuropathy (nitrofurantoin).

What does ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin target?

ciprofloxacin, cotrimoxazole-trimethoprim, macrodantin targets Bacterial DNA gyrase, topoisomerase IV, dihydrofolate reductase, bacterial DNA and is a Fluoroquinolone, Sulfonamide-diaminopyrimidine combination, Nitrofuran.

Related